Efficacy and safe of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes - The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)

Knopp, RH; D'Emden, M; Smilde, JG; Pocock, SJ; (2006) Efficacy and safe of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes - The Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN). Diabetes care, 29 (7). pp. 1478-1485. ISSN 0149-5992 DOI: https://doi.org/10.2337/dc05-2415

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.2337/dc05-2415

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar